They Wanted a Quick Fix for Hair Loss. Instead, These Young Men Got Sick.
Mark Millich, 26 years old and insecure about his thinning hair, was curious about the ads he saw promising to reverse his ...
Hims & Hers (HIMS) Investors Pulling Their Hair Out Over Pills Side-Effects
Shares in telehealth business Hims & Hers Health (HIMS) dropped over 6% today after reports that it and peers are marketing ...
Army vet, 26, says his genitals shrank, changed shape after taking popular hair loss drug
In recent years, telehealth companies like Hims and Keeps have revolutionized access to hair loss treatments by offering ...
ConsumerAffairs18h
Hair loss your biggest problem? Try finasteride and you may have a worse problem
Believe it or not, there's something worse than male pattern baldness. It's depression, plunging libido and shrinking ...
Telehealth companies aggressively marketing hair-loss medicine to men, WSJ says
Telehealth companies like Hims & Hers (HIMS) are aggressively marketing hair-loss medications to young men, with some patients saying they ...
Hims & Hers bought a skincare startup for $190 million 4 years ago. Today it shut it down.
Hims & Hers is shutting down Apostrophe, the skincare company it acquired in 2021, after a tumultuous month for the public ...
Hims & Hers abandons dermatology business Apostrophe it paid $190M for
Hims & Hers Health ( NYSE: HIMS) shut down Apostrophe on Friday, the skincare business it acquired in 2019 for $190M. A ...
This Could Be a Huge Blow to Hims & Hers Health Stock
Hims & Hers Health (NYSE: HIMS) has been a top healthcare stock to own over the past five years, soaring by around 350% ...
Hims & Hers: The Odds Are In Your Favor, Here's How To Take Advantage (Rating Upgrade)
Hims & Hers Health's revenue grew 69% YoY, boosting its outlook. See why HIMS stock’s growth potential and high implied ...
Healthline7d
The 8 Best Shampoos for Thinning Hair
Hims Topical Finasteride & Minoxidil Spray is ... this specific product isn’t FDA-approved. Thinning hair and hair loss can occur for a variety of reasons. Determining the underlying cause ...
Hims & Hers' Weight-Loss Bet Hits a Wall--Is the Stock's $6 Billion Surge About to Unravel?
With the FDA shutting down its key revenue stream, Hims faces a tough road ahead--can it justify its valuation?
Fierce Healthcare2d
Hims & Hers shutters Apostrophe in favor of its own tele-dermatology offerings
Telehealth personalized care company Hims & Hers shuttered a central part of its dermatology offering, skincare brand Apostrophe, to "simplify" its dermatology offerings and operation | Hims & Hers ...